Department of Epidemiology, German Institute of Human Nutrition Potsdam-Rehbrücke, Nuthetal, Germany.
Am J Clin Nutr. 2012 Jun;95(6):1468-76. doi: 10.3945/ajcn.111.014670. Epub 2012 May 2.
Genetic polymorphisms of transcription factor 7-like 2 (TCF7L2) have been associated with type 2 diabetes and BMI.
The objective was to investigate whether TCF7L2 HapA is associated with weight development and whether such an association is modulated by protein intake or by the glycemic index (GI).
The investigation was based on prospective data from 5 cohort studies nested within the European Prospective Investigation into Cancer and Nutrition. Weight change was followed up for a mean (±SD) of 6.8 ± 2.5 y. TCF7L2 rs7903146 and rs10885406 were successfully genotyped in 11,069 individuals and used to derive HapA. Multiple logistic and linear regression analysis was applied to test for the main effect of HapA and its interaction with dietary protein or GI. Analyses from the cohorts were combined by random-effects meta-analysis.
HapA was associated neither with baseline BMI (0.03 ± 0.07 BMI units per allele; P = 0.6) nor with annual weight change (8.8 ± 11.7 g/y per allele; P = 0.5). However, a previously shown positive association between intake of protein, particularly of animal origin, and subsequent weight change in this population proved to be attenuated by TCF7L2 HapA (P-interaction = 0.01). We showed that weight gain becomes independent of protein intake with an increasing number of HapA alleles. Substitution of protein with either fat or carbohydrates showed the same effects. No interaction with GI was observed.
TCF7L2 HapA attenuates the positive association between animal protein intake and long-term body weight change in middle-aged Europeans but does not interact with the GI of the diet.
转录因子 7 样 2(TCF7L2)的遗传多态性与 2 型糖尿病和 BMI 有关。
目的是研究 TCF7L2 HapA 是否与体重发展有关,以及这种关联是否受蛋白质摄入或血糖指数(GI)的调节。
该研究基于嵌套在欧洲癌症前瞻性调查和营养研究中的 5 项队列研究的前瞻性数据。体重变化的随访时间平均为 6.8±2.5 年。成功对 11069 名个体进行了 TCF7L2 rs7903146 和 rs10885406 的基因分型,并用于推导 HapA。应用多元逻辑和线性回归分析来检验 HapA 的主要作用及其与膳食蛋白质或 GI 的相互作用。通过随机效应荟萃分析对队列分析进行合并。
HapA 既与基线 BMI 无关(每个等位基因 0.03±0.07 BMI 单位;P=0.6),也与每年体重变化无关(每个等位基因 8.8±11.7 g/y;P=0.5)。然而,该人群中摄入蛋白质(特别是动物源性蛋白质)与随后体重变化之间先前显示的正相关,被 TCF7L2 HapA 减弱(P 交互=0.01)。我们表明,随着 HapA 等位基因数量的增加,体重增加变得与蛋白质摄入无关。用脂肪或碳水化合物替代蛋白质会产生相同的效果。未观察到与 GI 的相互作用。
TCF7L2 HapA 减弱了动物蛋白摄入与中年欧洲人体重长期变化之间的正相关,但与饮食 GI 没有相互作用。